Does Molecular Genotype Provide Useful Information in the Management of Radioiodine Refractory Thyroid Cancers? Results of a Retrospective Study.

about

Current Advances in Thyroid Cancer Management. Are We Ready for the Epidemic Rise of Diagnoses?Therapeutic options in papillary thyroid carcinoma: current guidelines and future perspectives.

P2860

Q38614394-B1B28A44-D1D0-454A-BA32-913B899D7258 Q38844362-5241731B-C7B5-4CF6-80BF-5815C62F63FF

P2860

Does Molecular Genotype Provide Useful Information in the Management of Radioiodine Refractory Thyroid Cancers? Results of a Retrospective Study.

Item

http://www.wikidata.org/entity/Q40629784

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Does Molecular Genotype Provid ...... ults of a Retrospective Study.

@en

type

Item

label

Does Molecular Genotype Provid ...... ults of a Retrospective Study.

@en

prefLabel

Does Molecular Genotype Provid ...... ults of a Retrospective Study.

@en

P1476

Does Molecular Genotype Provid ...... ults of a Retrospective Study.

@en

P2093

Anne-Laure Giraudet

http://www.w3.org/2001/XMLSchema#string

Christelle de la Fouchardiere

http://www.w3.org/2001/XMLSchema#string

Claire Bournaud-Salinas

http://www.w3.org/2001/XMLSchema#string

Jean-Christophe Lifante

http://www.w3.org/2001/XMLSchema#string

Jean-Louis Peix

http://www.w3.org/2001/XMLSchema#string

Marie-Eve Fondrevelle

http://www.w3.org/2001/XMLSchema#string

Myriam Decaussin-Petrucci

http://www.w3.org/2001/XMLSchema#string

Nadia Oussaid

http://www.w3.org/2001/XMLSchema#string

Olfa Derbel

http://www.w3.org/2001/XMLSchema#string

Pierre-Paul Bringuier

http://www.w3.org/2001/XMLSchema#string

P2860

Progress in molecular-based management of differentiated thyroid cancer

RAS mutations in thyroid cancer

Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer

BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study

Cancer incidence trends among Asian American populations in the United States, 1990-2008

PIK3CA mutations frequently coexist with RAS and BRAF mutations in patients with advanced cancers.

Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy.

Relative quantification of PIK3CA gene expression level in fine-needle aspiration biopsy thyroid specimens collected from patients with papillary thyroid carcinoma and non-toxic goitre by real-time RT-PCR.

BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer.

Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA, and AKT1.

P2888

s11523-015-0380-y

P304

71-82

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11523-015-0380-Y

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Francoise Borson-Chazot

Jonathan Lopez

P577

2015-08-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281141315

http://www.w3.org/2001/XMLSchema#string

P698

26285789

http://www.w3.org/2001/XMLSchema#string

Does Molecular Genotype Provide Useful Information in the Management of Radioiodine Refractory Thyroid Cancers? Results of a Retrospective Study.

about

P2860

P2860

Does Molecular Genotype Provide Useful Information in the Management of Radioiodine Refractory Thyroid Cancers? Results of a Retrospective Study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P698